精神病患者合并糖尿病的用药回顾

The Brown University Psychopharmacology Update Pub Date : 2025-07-01 DOI:10.1002/pu.31333

Y. W. Francis Lam Pharm.D., FCCP

{"title":"精神病患者合并糖尿病的用药回顾","authors":"Y. W. Francis Lam Pharm.D., FCCP","doi":"10.1002/pu.31333","DOIUrl":null,"url":null,"abstract":"<p>Research has suggested a possible link between antidepressants and increased risk of type 2 diabetes (Salvi et al., 2017). A higher prevalence of diabetes has also been reported in patients with schizophrenia (De Hert et al., 2009). Management of concurrent diabetes and psychiatric disorders could lead to polypharmacy, with risks of increased adverse drug effects and potential drug-drug interactions.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"36 8","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Medication review in psychiatric patients with diabetes\",\"authors\":\"Y. W. Francis Lam Pharm.D., FCCP\",\"doi\":\"10.1002/pu.31333\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Research has suggested a possible link between antidepressants and increased risk of type 2 diabetes (Salvi et al., 2017). A higher prevalence of diabetes has also been reported in patients with schizophrenia (De Hert et al., 2009). Management of concurrent diabetes and psychiatric disorders could lead to polypharmacy, with risks of increased adverse drug effects and potential drug-drug interactions.</p>\",\"PeriodicalId\":22275,\"journal\":{\"name\":\"The Brown University Psychopharmacology Update\",\"volume\":\"36 8\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Brown University Psychopharmacology Update\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/pu.31333\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Brown University Psychopharmacology Update","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/pu.31333","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

研究表明，抗抑郁药与2型糖尿病风险增加之间可能存在联系（Salvi et al., 2017）。据报道，精神分裂症患者的糖尿病患病率也较高（De Hert et al., 2009）。并发糖尿病和精神疾病的管理可能导致多重用药，增加药物不良反应和潜在药物相互作用的风险。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Medication review in psychiatric patients with diabetes

Research has suggested a possible link between antidepressants and increased risk of type 2 diabetes (Salvi et al., 2017). A higher prevalence of diabetes has also been reported in patients with schizophrenia (De Hert et al., 2009). Management of concurrent diabetes and psychiatric disorders could lead to polypharmacy, with risks of increased adverse drug effects and potential drug-drug interactions.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

The Brown University Psychopharmacology Update

自引率

0.00%

发文量